drugset / Trial / NCT00232141
Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Study to determine if pregabalin is more effective than placebo in treating subjects with nerve pain associated with HIV neuropathy.
Timeline
- Start
- 2005-10
- Primary completion
- 2007-11
- Completion
- 2007-11
Outcome
Missed primary endpoint
registry analysis (unspecified test); Pregabalin vs Placebo; p = 0.3914; Mean Difference (Final Values) -0.25 (95% CI -0.83 to 0.32); ANCOVA NCT00232141 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 300 mg | — |